Emtricitabine and Metformin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among 163 people who take Emtricitabine and Metformin. Common interactions include alopecia among females, and foetal exposure during pregnancy among males.
The phase IV clinical study analyzes what interactions people who take Emtricitabine and Metformin have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
163 people who take Emtricitabine and Metformin together, and have interactions are studied.
What is Emtricitabine?
Emtricitabine has active ingredients of emtricitabine. Currently, eHealthMe is studying from 6,139 Emtricitabine users.
What is Metformin?
Metformin has active ingredients of metformin hydrochloride. It is used in diabetes. Currently, eHealthMe is studying from 440,945 Metformin users.
Number of Emtricitabine and Metformin reports submitted per year:
Emtricitabine and Metformin drug interactions by gender *:
Emtricitabine and Metformin drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Emtricitabine and Metformin?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- T.Audi Yanto, I.Huang, F.Nathania Kosasih, NP Hardjo Lugito, "Nightmare and Abnormal Dreams: Rare Side Effects of Metformin?", Case Reports in Endocrinology, 2018 Jan .
- Al-Hamdy RA, "Assessment of electrolytes and HbA1c in type 2 diabetic patients using metformin and evaluation of guidelines obedience regarding renal impairment", J.Thi-Qar Sci., 2015 Jan .
- Wiwanitkit S, Wiwanitkit V, "Metformin and sleep disorders", Indian journal of endocrinology and metabolism, 2012 Jan .
Related studies
Drug side effects by duration, gender and age:
- Emtricitabine side effects (6,139 reports)
- Metformin side effects (440,945 reports)
Common Emtricitabine drug interactions:
- Emtricitabine and Tenofovir disoproxil fumarate: 1,695 reports
- Emtricitabine and Efavirenz: 1,578 reports
- Emtricitabine and Ritonavir: 1,422 reports
- Emtricitabine and Darunavir: 837 reports
- Emtricitabine and Nevirapine: 743 reports
- Emtricitabine and Raltegravir: 685 reports
- Emtricitabine and Abacavir: 599 reports
- Emtricitabine and Dolutegravir: 583 reports
- Emtricitabine and Didanosine: 432 reports
- Emtricitabine and Stavudine: 305 reports
Browse interactions between Emtricitabine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Metformin drug interactions:
- Metformin and Aspirin: 62,208 reports
- Metformin and Lisinopril: 52,043 reports
- Metformin and Simvastatin: 38,874 reports
- Metformin and Amlodipine: 36,856 reports
- Metformin and Omeprazole: 35,087 reports
- Metformin and Furosemide: 31,739 reports
- Metformin and Lantus: 29,762 reports
- Metformin and Gabapentin: 27,844 reports
- Metformin and Glipizide: 26,782 reports
- Metformin and Pantoprazole: 23,694 reports
Browse interactions between Metformin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on emtricitabine and metformin hydrochloride (the active ingredients of Emtricitabine and Metformin, respectively), and Emtricitabine and Metformin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Emtricitabine and Metformin.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hydroxyurea and Urosepsis - a second ago
- Minipress and Bradycardia - 4 seconds ago
- Fluticasone Propionate and Emla drug interaction - 11 seconds ago
- Aripiprazole and Weight Loss - 23 seconds ago
- Cefdinir and Relistor drug interaction - 32 seconds ago
- Carvedilol and Vision Blurred - 33 seconds ago
- Ifosfamide and Acute Graft Versus Host Disease - 34 seconds ago
- Avonex and Bactroban drug interaction - 35 seconds ago
- Actos and Cefoxitin drug interaction - 36 seconds ago
- Purinethol and Cyanocobalamin drug interaction - 51 seconds ago